ClaimParrot vs Claimable: which fits a behavioral-health denial?

How did we compare these tools?

We compared both tools on the same criteria: who each is for, what you upload, what you get, behavioral-health depth, payer routing, deadlines, who submits, review workflow, HIPAA and BAA statements, and public price. Competitor facts come from Claimable's own website on October 14, 2026. We did not test Claimable's paid service.

• Sources: Claimable's home, provider and health-system pages, listed below with the date we checked them. Where its site says nothing about a criterion, the table says so instead of guessing.
• Outcome figures left out: Claimable publishes success-rate and turnaround figures on its site. They are vendor-reported without a stated method, so we did not include them.
• ClaimParrot facts come from its own public pages. ClaimParrot is new and has no published outcome data.
• Our bias: ClaimParrot publishes this page and sells a competing product. Read it with that in mind and check the sources yourself.

Who is each tool built for?

Claimable is built mainly for patients. Its provider page says it gives patients what they need to file an appeal on their own, with the provider supplying documents. ClaimParrot is built for the provider side: behavioral-health programs and the billing companies that work their denial queues, with a person checking every packet.

Claimable also runs partner tracks for health systems and pharma or hub teams. Its health-system page describes an API that connects to EHR and revenue-cycle systems, tracking from submission to resolution, and a dashboard that breaks denials down by payer, therapy, denial type and outcome.

ClaimParrot's users are utilization-review staff, billers and clinical reviewers at IOP, PHP, residential, inpatient psychiatric, detox and SUD, outpatient and ABA programs, plus RCM firms running several clients. See ClaimParrot for behavioral-health providers and for billing companies.

What does each tool do with a denial?

Claimable writes an evidence-based appeal from the patient's story, clinical research and policy details, points out where the plan did not follow its own rules, then mails and faxes it and sends reminders. ClaimParrot takes a de-identified summary of the denial, routes it, lists the evidence to attach and drafts an editable packet that a person checks.

• Claimable: searches precedents, policies and studies for evidence, suggests recipients, and offers expedited delivery and tracking. It says it does not take denials caused by administrative errors or missing information.
• ClaimParrot: works from the stated reason, care setting, review stage and any criteria set your team copies from the notice, flags missing support instead of inventing it, and writes a neutral peer-to-peer brief from the payer's rationale.
• ClaimParrot: names criteria sets such as ASAM, LOCUS, InterQual or MCG when the notice cites them, and never reproduces their text.

How much behavioral-health depth does each offer?

Claimable's site lists medication and therapy categories such as asthma, GLP-1s, migraine and autoimmune conditions, and its health-system page names oncology, infusion and rare disease. We found no behavioral-health page or feature. ClaimParrot's denial workflow is built for behavioral health: level of care, concurrent review, continued-stay denials, ABA and parity arguments.

Behavioral-health denials turn on details a general appeal letter can miss: the level of care requested versus the one the plan approved, the dates covered by a concurrent-review decision, the criteria set the reviewer used, and whether the plan limits mental-health benefits more strictly than medical ones. Our level-of-care denial guide and continued-stay guide cover those details.

If a patient's denial is for a specialty medication on Claimable's list, Claimable is built for exactly that. Its provider page says it supports more than 85 treatments; check its site for the current list.

What does each say about HIPAA and BAAs?

Claimable says data is handled in full HIPAA compliance, and its provider page says providers, as covered entities, must sign a business associate agreement and be verified before sharing PHI. ClaimParrot accepts no PHI and signs no BAA: requests are de-identified, and packets come back with placeholders your team fills in.

Claimable shows a SOC 2 badge on several pages; we found no written statement of the report type or date. ClaimParrot's site makes no SOC 2 claim. Its HIPAA page and Trust & security page explain why it needs no BAA: it receives only de-identified case details, and the identifiers stay in your own systems.

Under HHS guidance, a cloud service that creates, receives, maintains or transmits electronic PHI for a covered entity is a business associate and needs a BAA, even if it cannot decrypt the data. Whichever tool you choose, confirm a BAA before any tool receives patient records, or send de-identified information only.

What does each cost?

Claimable charges a flat $39.95 per appeal plus shipping and says many patients pay nothing through its partners (checked October 14, 2026). It publishes no separate provider or health-system price. ClaimParrot charges $29 per appeal packet, or $99 for a level-of-care packet, the first packet is free, and Appeal Desk plans start at $590 a month.

Both price one appeal at a time, but the packages differ: Claimable includes delivery to the payer, while ClaimParrot includes a person checking the packet and leaves submission to your staff. Full details are on the pricing page.

Where is each tool strong?

Claimable's strengths are end-to-end delivery for patients, deep evidence and policy research for specialty-drug denials, free access for many patients through partners, and an analytics and API option for health systems. ClaimParrot's strengths are behavioral-health routing, an evidence checklist matched to the denial, peer-to-peer preparation and a person checking every packet.

• Claimable: it sends the appeal by fax and first-class mail and tracks it, so the patient does not have to.
• Claimable: a health-system option with API integration and denial analytics by payer, therapy and denial type.
• ClaimParrot: the same notice routes the same way every time, because routing is application code, not model output.
• ClaimParrot's limits: it is new and has no published outcome data, it accepts de-identified cases only, and your team fills in the patient details and submits the appeal.

Who should choose which?

Choose Claimable if you are a patient, or a practice helping a patient, with a specialty-medication or infusion denial and you want the appeal mailed, faxed and tracked for one flat fee. Choose ClaimParrot if you are a behavioral-health program or billing company working recurring level-of-care, concurrent-review or ABA denials as a team.

The tools overlap very little, so some practices could use both: a patient appeals a specialty-drug denial through Claimable while the program's billing team works its own level-of-care denials in ClaimParrot. Before choosing, run a fictional case through the denial lab, or start from a free IOP appeal letter template.